Displaying items by tag: division of hematology and oncology

Assistant Professor Noha Sharafeldin, MBBCh, Ph.D., presented cancer-related findings from the massive N3C database of records from COVID-positive patients at 55 institutions nationwide, including UAB. Results — including a significant increase in risk of death among patients who recently had chemotherapy — were published simultaneously in the Journal of Clinical Oncology.

This year, the university recognizes 50 years of service by Jeanne Hutchison, Ph.D., and Ferdinand Urthaler, M.D., and 45 years of service by Robert Kim M.D., and Joseph Lovetto. In addition, 294 employees with 20 or more years and 904 with five, 10 and 15 years will honored for their longevity.

In a talk at UAB on March 6, the NIH director shared his thoughts on exceptional opportunities for science and young scientists — and highlighted several exciting UAB projects.

UAB-led study finds that genetic variations associated with cognitive decline after BMT identify high-risk patients more accurately than current methods.

An innovative study led by Luciano Costa, M.D., Ph.D., generated national buzz for its success in beating back blood cancer — and enrolling African American patients.

Single-cell sequencing enables researchers to study disease as never before — even skipping through time to follow crucial populations. UAB experts explain what all the fuss is about and how to get started in single-cell research — a field that is wide open for discovery.

Noha Sharafeldin, MBBCh, Ph.D., of the Institute for Cancer Outcomes and Survivorship, used UAB’s supercomputer to identify biomarkers linked with cognitive impairment in patients who received a blood or marrow transplant. She’s also testing a way to repair the damage.

Nurse practitioner details physical, emotional toll of disease in A Place I Didn't Want to Go: My Victory Over Cancer.